Safety and efficacy of remimazolam besylate in patients undergoing colonoscopy: A multicentre, single-blind, randomized, controlled, phase Ⅲ trial

Overview of attention for article published in Frontiers in Pharmacology, October 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 13 Mendeley

So far, Altmetric has seen 1 X post from an account with 5,890 followers.

New Research: Safety and efficacy of remimazolam besylate in patients undergoing colonoscopy: A multicentre, single-blind, randomized, controlled, phase Ⅲ trial https://t.co/YQf7GedKTG #pharmacology

05 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.